Skip to content

Dr. Reddy’s launches generic Concerta in U.S.

September 3, 2020

Dr. Reddy’s Laboratories (NYSE:RDY) commences the U.S. commercial launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, 18 mg, 27 mg, 36 mg and 54 mg, a therapeutic equivalent generic version of Johnson & Johnson’s (NYSE:JNJ) ADHD med Concerta (methylphenidate Hydrochloride) Extended-Release Tablets, 18 mg, 27 mg, 36 mg, and 54 mg.

Per IQVIA, the U.S. market is ~$1.16B.

https://seekingalpha.com/news/3611343-dr-reddys-launches-generic-concerta-in-u-s

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: